RU
Tuesday,
23 May 2017
Moscow
St.petersburg
London
Subscribe to our NEWSLETTER
15 May 2017

Organizational changes in AstraZeneca

Changes in Russia and Eurasia region

AstraZeneca announces organizational changes that concerns Russia and Eurasia region.

 – Irina Panarina has been appointed to the position of General Manager of AstraZeneca, Russia and Eurasia. Irina will be responsible for AstraZeneca business in Russia & Eurasia Area and lead AstraZeneca Russia.
 – Iskra Reic, previously AstraZeneca Russia & Eurasia Area Vice President and AstraZeneca Russia General Manager, is appointed Executive Vice President for Europe. Iskra will be responsible for sales, marketing and commercial operations across AstraZeneca businesses in 30 European countries.

These appointments reflect the commitment of AstraZeneca to talent development.

About Irina Panarina, AstraZeneca General Manager, Russia and Eurasia

Irina Panarina has worked for AstraZeneca since 2009. In October 2015 Irina joined the Russian team as Cardiovascular and Metabolic Disease Business Unit Head. Before coming to Russia, Irina Panarina held the position of General Manager at AstraZeneca Ukraine.

Prior to joining AstraZeneca Irina held regional roles at GSK Pharma headquarters in London, UK.

Irina Panarina has work experience in marketing, product portfolio management, people development.

Irina Panarina has degrees from Newcastle University & South Bank University. She also holds MBA degree from INSEAD Business School.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.